ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma

Ann Surg Oncol. 2022 Sep;29(9):6029-6030. doi: 10.1245/s10434-022-11878-6. Epub 2022 May 18.

Authors

Anne E O'Shea¹, Elizabeth L Carpenter², Daniel W Nelson³, Timothy J Vreeland²

Affiliations

¹ Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA. anne.oshea5@gmail.com.
² Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA.
³ Department of Surgery, William Beaumont Army Medical Center, El Paso, TX, USA.

PMID: 35583695
DOI: 10.1245/s10434-022-11878-6

No abstract available

Publication types

Comment

MeSH terms

Adenocarcinoma* / drug therapy
Chemoradiotherapy
Humans
Neoadjuvant Therapy
Pancreatic Neoplasms* / pathology